The Business of Pain Presents: The Next Big Thing
Where Pain Medicine, Science and Business Intersect Loews Vanderbilt Hotel, Nashville, TN
Where Pain Medicine, Science and Business Intersect Loews Vanderbilt Hotel, Nashville, TN
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
The comorbidity, co-prescribing, and co-occurrence of disability among persons with chronic pain create greater challenges in managing each condition and reducing impact. Pain cannot be managed in isolation. (Wallace, 2004) The Kaua'i Pain Conference curriculum addresses biopsychosocial dimensions of pain:
